School of Public Health, Curtin University, Perth, WA, Australia.
Menzies Centre for Health Policy, School of Public Health, University of Sydney, NSW, Australia.
BJOG. 2018 Jan;125(2):183-192. doi: 10.1111/1471-0528.14906. Epub 2017 Oct 3.
Little is known about the risk of non-recurrent adverse birth outcomes.
To evaluate the risk of stillbirth, preterm birth (PTB), and small for gestational age (SGA) as a proxy for fetal growth restriction (FGR) following exposure to one or more of these factors in a previous birth.
We searched MEDLINE, EMBASE, Maternity and Infant Care, and Global Health from inception to 30 November 2016.
Studies were included if they investigated the association between stillbirth, PTB, or SGA (as a proxy for FGR) in two subsequent births.
Meta-analysis and pooled association presented as odds ratios (ORs) and adjusted odds ratios (aORs).
Of the 3399 studies identified, 17 met the inclusion criteria. A PTB or SGA (as a proxy for FGR) infant increased the risk of subsequent stillbirth ((pooled OR 1.70; 95% confidence interval, 95% CI, 1.34-2.16) and (pooled OR 1.98; 95% CI 1.70-2.31), respectively). A combination of exposures, such as a preterm SGA (as a proxy for FGR) birth, doubled the risk of subsequent stillbirth (pooled OR 4.47; 95% CI 2.58-7.76). The risk of stillbirth also varied with prematurity, increasing three-fold following PTB <34 weeks of gestation (pooled OR 2.98; 95% CI 2.05-4.34) and six-fold following preterm SGA (as a proxy for FGR) <34 weeks of gestation (pooled OR 6.00; 95% CI 3.43-10.49). A previous stillbirth increased the risk of PTB (pooled OR 2.82; 95% CI 2.31-3.45), and subsequent SGA (as a proxy for FGR) (pooled OR 1.39; 95% CI 1.10-1.76).
The risk of stillbirth, PTB, or SGA (as a proxy for FGR) was moderately elevated in women who previously experienced a single exposure, but increased between two- and three-fold when two prior adverse outcomes were combined. Clinical guidelines should consider the inter-relationship of stillbirth, PTB, and SGA, and that each condition is an independent risk factor for the other conditions.
Risk of adverse birth outcomes in next pregnancy increases with the combined number of previous adverse events.
Why and how was the study carried out? Each year, around 2.6 million babies are stillborn, 15 million are born preterm (<37 weeks of gestation), and 32 million are born small for gestational age (less than tenth percentile for weight, smaller than usually expected for the relevant pregnancy stage). Being born preterm or small for gestational age can increase the chance of long-term health problems. The effect of having a stillbirth, preterm birth, or small-for-gestational-age infant in a previous pregnancy on future pregnancy health has not been summarised. We identified 3399 studies of outcomes of previous pregnancies, and 17 were summarised by our study. What were the main findings? The outcome of the previous pregnancy influenced the risk of poor outcomes in the next pregnancy. Babies born to mothers who had a previous preterm birth or small-for-gestational-age birth were more likely to be stillborn. The smaller and the more preterm the previous baby, the higher the risk of stillbirth in the following pregnancy. The risk of stillbirth in the following pregnancy was doubled if the previous baby was born both preterm and small for gestational age. Babies born to mothers who had a previous stillbirth were more likely to be preterm or small for gestational age. What are the limitations of the work? We included a small number of studies, as there are not enough studies in this area (adverse birth outcomes followed by adverse cross outcomes in the next pregnancy). We found very few studies that compared the risk of small for gestational age after preterm birth or stillbirth. Definitions of stillbirth, preterm birth categories, and small for gestational age differed across studies. We did not know the cause of stillbirth for most studies. What are the implications for patients? Women who have a history of poor pregnancy outcomes are at greater risk of poor outcomes in following pregnancies. Health providers should be aware of this risk when treating patients with a history of poor pregnancy outcomes.
人们对非复发性不良出生结局的风险知之甚少。
评估在先前的一次妊娠中暴露于一种或多种以下因素后,仍有死胎、早产(PTB)和小于胎龄儿(SGA)(作为胎儿生长受限(FGR)的替代指标)的风险。
我们检索了 MEDLINE、EMBASE、Maternity and Infant Care 和 Global Health 从创建到 2016 年 11 月 30 日的数据。
如果研究调查了两次连续妊娠中仍有死胎、PTB 或 SGA(作为 FGR 的替代指标)之间的关联,则纳入研究。
采用荟萃分析和汇总关联,以比值比(OR)和调整比值比(aOR)表示。
在 3399 项研究中,有 17 项符合纳入标准。PTB 或 SGA(作为 FGR 的替代指标)婴儿增加了随后仍有死胎的风险(汇总 OR 1.70;95%置信区间,95%CI,1.34-2.16)和(汇总 OR 1.98;95%CI 1.70-2.31),分别。多种暴露的组合,如早产 SGA(作为 FGR 的替代指标)的出生,使随后仍有死胎的风险增加一倍(汇总 OR 4.47;95%CI 2.58-7.76)。死胎的风险也随早产程度而变化,妊娠 34 周前 PTB 增加三倍(汇总 OR 2.98;95%CI 2.05-4.34),妊娠 34 周前早产 SGA(作为 FGR 的替代指标)增加六倍(汇总 OR 6.00;95%CI 3.43-10.49)。先前的死胎增加了 PTB(汇总 OR 2.82;95%CI 2.31-3.45)和随后的 SGA(作为 FGR 的替代指标)(汇总 OR 1.39;95%CI 1.10-1.76)的风险。
在先前经历过单一暴露的妇女中,仍有死胎、PTB 或 SGA(作为 FGR 的替代指标)的风险中度升高,但当两个先前的不良结局合并时,风险增加两到三倍。临床指南应考虑死胎、PTB 和 SGA 之间的相互关系,以及每种情况都是其他情况的独立危险因素。
下一次妊娠中不良出生结局的风险随先前不良事件数量的增加而增加。
为什么以及如何进行这项研究?每年约有 260 万婴儿仍有死胎,1500 万婴儿早产(<37 周妊娠),3200 万婴儿小于胎龄(体重低于第十分位数,比相关妊娠阶段通常预期的要小)。早产或小于胎龄出生会增加长期健康问题的机会。先前有死胎、早产或小于胎龄儿的妊娠对未来妊娠健康的影响尚未得到总结。我们确定了 3399 项关于先前妊娠结局的研究,其中 17 项由我们的研究进行了总结。主要发现是什么?先前妊娠的结局影响了下次妊娠的不良结局风险。母亲先前有早产或小于胎龄儿的婴儿更容易仍有死胎。先前婴儿的胎龄越小、体重越轻,下次妊娠的死胎风险就越高。如果前一个婴儿既早产又小于胎龄,那么死胎的风险就会增加一倍。母亲先前有死胎的婴儿更容易早产或小于胎龄。这项研究的局限性是什么?我们纳入了少数研究,因为这方面的研究(下一次妊娠中早产或仍有死胎后的不良交叉结局)并不多。我们发现很少有研究比较早产或仍有死胎后小于胎龄儿的风险。研究之间的死胎、早产类别和小于胎龄儿的定义不同。我们不知道大多数研究中死胎的原因。这对患者有什么影响?有不良妊娠结局史的妇女在随后的妊娠中发生不良结局的风险更高。当治疗有不良妊娠结局史的患者时,医疗服务提供者应该意识到这一风险。